ライフサイエンスコーパス: phosphaturic

1 ceptor complex may cause a resistance to the phosphaturic action of FGF23.

2 rinary phosphate excretion suggests that the phosphaturic action of MEPE correlates with a significan

3 The phosphaturic activity of FGF23 is abrogated by proteolyt

4 tions of bone, such as those mediated by the phosphaturic and 1,25(OH)2D-regulating hormone FGF23, an

5 869206 for 8 weeks induced an unabated acute phosphaturic and hypophosphatemic effect, but had no sta

6 lcium and by acting as a co-receptor for the phosphaturic and vitamin D-regulating hormone fibroblast

7 we found no evidence for intestinal-specific phosphaturic control mechanisms in humans.

8 This phosphaturic effect lowered plasma phosphate levels in W

9 The phosphaturic effect of intestinal phosphate is specific

10 The phosphaturic effect was present in FGF23-null mice, indi

11 with CKD without interrupting the necessary phosphaturic effects of FGF23.

12 decreases in serum FGF23 levels through its phosphaturic effects, may be responsible for attenuating

13 senger, the plasma levels of the circulating phosphaturic factor FGF-23 were measured using a c-termi

14 The regulation of the phosphaturic factor fibroblast growth factor 23 (FGF23)

15 ms, and there is evidence that a circulating phosphaturic factor plays a role in the bone disease.

16 y expressed in such tumors, is a circulating phosphaturic factor that antagonizes renal Wnt-signaling

17 Fibroblast growth factor 23 (FGF23) is a phosphaturic factor that suppresses both sodium-dependen

18 increased expression of the MEPE and another phosphaturic factor, Fgf23.

19 (XLH) by increasing levels of a circulating phosphaturic factor.

20 FGF23 is a candidate for this phosphaturic factor.

21 e that is a candidate for the tumor-secreted phosphaturic factor.

22 factor-23 (FGF-23) is one of the circulating phosphaturic factors associated with renal phosphate was

23 te that elevated levels of novel circulating phosphaturic factors such as fibroblast growth factor 23

24 hich results in the accumulation of putative phosphaturic factors, called phosphatonins.

25 correlated with reduced serum levels of the phosphaturic hormone FGF23 and increased protein express

26 thyroidism (HPT) and serum elevations in the phosphaturic hormone FGF23, which may be maladaptive and

27 in and is associated with high levels of the phosphaturic hormone fibroblast growth factor 23 (FGF23)

28 d by increased synthesis of the bone-derived phosphaturic hormone fibroblast growth factor 23 (FGF23)

29 gical mechanism, potentially mediated by the phosphaturic hormone fibroblast growth factor-23 (FGF-23

30 ine and serum phosphorus levels, circulating phosphaturic hormone fibroblast growth factor-23 levels,

31 high or low circulating levels of the novel phosphaturic hormone fibroblastic growth factor 23 (FGF2

32 stones suggesting that bnl is the endogenous phosphaturic hormone in adult flies.

33 on of fibroblast growth factor 23 (FGF23), a phosphaturic hormone related to tumor necrosis factor al

34 roblast growth factor-23 (FGF-23) is a novel phosphaturic hormone that also inhibits renal 1alpha-hyd

35 Fibroblast growth factor (FGF) 23 is a phosphaturic hormone that directly targets cardiac myocy

36 f FGF23 may be to act as a counterregulatory phosphaturic hormone to maintain phosphate homeostasis i

37 Serum levels of FGF23, a phosphaturic hormone, increase at the earliest stages of

38 vels of fibroblast growth factor (FGF)-23, a phosphaturic hormone, increase from the early stages of

39 ic growth factor 23 (FGF23) is a circulating phosphaturic hormone.

40 measured concentrations of calciotropic and phosphaturic hormones, and urine and serum calcium and i

41 Thus, the two major phosphaturic hormones, PTH and FGF23, have opposing effe

42 onversely, microinjection of adults with the phosphaturic human hormone fibroblast growth factor 23 (

43 Recently, several phosphaturic peptides such as fibroblast growth factor-2

44 The earliest phosphaturic response occurred after plasma PO4 and para

45 To determine whether serotonin modulates the phosphaturic response to PTH during conditions of dietar

46 n phosphate-replete rats, and attenuates the phosphaturic response to PTH in phosphate-deprived rats.

47 Klotho is a novel phosphaturic substance that acts as an enzyme in the pro